Prevalence of statin intolerance: a meta-analysis
Aims Statin intolerance (SI) represents a significant public health problem for which precise
estimates of prevalence are needed. Statin intolerance remains an important clinical …
estimates of prevalence are needed. Statin intolerance remains an important clinical …
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Y Duan, K Gong, S Xu, F Zhang, X Meng… - Signal Transduction and …, 2022 - nature.com
Disturbed cholesterol homeostasis plays critical roles in the development of multiple
diseases, such as cardiovascular diseases (CVD), neurodegenerative diseases and …
diseases, such as cardiovascular diseases (CVD), neurodegenerative diseases and …
[HTML][HTML] Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
Background Statin therapy is effective for the prevention of atherosclerotic cardiovascular
disease and is widely prescribed, but there are persisting concerns that statin therapy might …
disease and is widely prescribed, but there are persisting concerns that statin therapy might …
A review on coronary artery disease, its risk factors, and therapeutics
AK Malakar, D Choudhury, B Halder… - Journal of cellular …, 2019 - Wiley Online Library
Coronary artery disease (CAD) is one of the major cardiovascular diseases affecting the
global human population. This disease has been proved to be the major cause of death in …
global human population. This disease has been proved to be the major cause of death in …
Citations, citation indicators, and research quality: An overview of basic concepts and theories
Citations are increasingly used as performance indicators in research policy and within the
research system. Usually, citations are assumed to reflect the impact of the research or its …
research system. Usually, citations are assumed to reflect the impact of the research or its …
Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving …
H Watanabe, T Domei, T Morimoto, M Natsuaki… - Jama, 2019 - jamanetwork.com
Importance Very short mandatory dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
Statin safety and associated adverse events: a scientific statement from the American Heart Association
CB Newman, D Preiss, JA Tobert… - … , and vascular biology, 2019 - Am Heart Assoc
One in 4 Americans> 40 years of age takes a statin to reduce the risk of myocardial
infarction, ischemic stroke, and other complications of atherosclerotic disease. The most …
infarction, ischemic stroke, and other complications of atherosclerotic disease. The most …
Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease
AS Abdelhamid, TJ Brown, JS Brainard… - Cochrane Database …, 2018 - cochranelibrary.com
Background Researchers have suggested that omega‐3 polyunsaturated fatty acids from
oily fish (long‐chain omega‐3 (LCn3), including eicosapentaenoic acid (EPA) and …
oily fish (long‐chain omega‐3 (LCn3), including eicosapentaenoic acid (EPA) and …
Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline
D LeRoith, GJ Biessels, SS Braithwaite… - The Journal of …, 2019 - academic.oup.com
Objective The objective is to formulate clinical practice guidelines for the treatment of
diabetes in older adults. Conclusions Diabetes, particularly type 2, is becoming more …
diabetes in older adults. Conclusions Diabetes, particularly type 2, is becoming more …
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech… - New England journal …, 2017 - Mass Medical Soc
Background Evolocumab is a monoclonal antibody that inhibits proprotein convertase
subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels …
subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels …